Agios Pharmaceuticals | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
AbbVie USD 4.81B 1.54B 2024-12
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD 369.62M 544.73M 2025-03
Astellas Pharma JPY 60.55B 178.91B 2025-03
AstraZeneca USD 3.4B 1.74B 2025-03
Bayer EUR 1.83B 2.31B 2025-03
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Daiichi Sankyo JPY 80.63B 1.78B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Exelixis USD 205.69M 20.92M 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Incyte USD 234.19M 172.64M 2025-03
Ionis Pharmaceuticals USD -147000000 40M 2025-03
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Novartis USD 4.66B 269M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Agios Pharmaceuticals Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.